HITEN SONI: Open Payments
NPI 1942492137 · LAWRENCE, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,774 in 34 payments from 12 companies in 2025. Trend: 2023 $996 · 2024 $3,527 · 2025 $5,774
Consulting: $5,159Food & beverage: $615
| Company | Payments | Amount |
|---|---|---|
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $5,159 |
| Vanda Pharmaceuticals Inc. | 11 | $193 |
| Otsuka America Pharmaceutical, Inc. | 3 | $82 |
| Janssen Pharmaceuticals, Inc | 4 | $67 |
| Axsome Therapeutics, Inc. | 3 | $64 |
| Noven Therapeutics, LLC | 3 | $54 |
| Supernus Pharmaceuticals, Inc. | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
Products named: REJOYN, HETLIOZ, REXULTI, SPRAVATO, Auvelity, Xelstrym, Qelbree, FANAPT.
Industry payments across KS — which companies pay providers there.
